A long-term follow-up study of diabetic foot ulcer using micronized acellular dermal matrix
- Abstract
- Treating a diabetic foot ulcer (DFU) extending to the tendon or bone can be a challenge for physicians. Recent studies have shown positive results of micronized acellular dermal matrix (ADM) treatment for treating DFU. However, studies on such ADM with a long-term follow-up are rare. Thus, the objective of this study was to retrospectively analyse patients treated with micronized ADM with a long-term follow-up to assess the effectiveness of the treatment and determine the recurrence rate. The rate of success of complete healing was 62.96% and the time of complete healing was 86.96 days in this study. The recurrence rate of DFUs was 41.17% in the overall group. However, it was only 23.52% in the micronized ADM group. The average duration of recurrence was 720.50 ± 505.12 days. The recurrence rate was 50% in weight bearing areas such as the plantar and heel. It was 12.5% in toes and non-weight bearing areas. In conclusion, micronized ADM can be used to effectively treat DFUs that have invaded ligaments or bones. A close follow-up of weight bearing area wounds will allow us to identify and treat recurrence early.
- All Author(s)
- J. Y. Byeon
; Y. S. Hwang
; H. J. Choi
; J. H. Kim
; D. W. Lee
- Issued Date
- 2022
- Type
- Article
- Keyword
- acellular dermis; diabetic foot; recurrence; therapeutics; ulcer
- Publisher
- Medicalhelplinescom Inc
- ISSN
- 1742-4801
- Citation Title
- International Wound Journal
- Citation Volume
- 20
- Citation Number
- 5
- Citation Start Page
- 1622
- Citation End Page
- 1637
- Language(ISO)
- eng
- DOI
- 10.1111/iwj.14018
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/3315
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.